nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

09.02.2018 | Original Article – Clinical Oncology

Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study

verfasst von: Dengke Teng, Guoqing Sui, Caimei Liu, Yu Wang, Yongxu Xia, Hui Wang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the safety and efficacy of ultrasound-guided low-power microwave ablation (MWA) for the treatment of papillary thyroid microcarcinoma (PTMC) with a 3-year follow-up.

Methods

A total of 21 nodules diagnosed as PTMC from the 15 patients were performed with MWA at a power of 20 W. The images of the nodules were recorded by ultrasound before MWA and 1, 3, 6, 12 months after MWA, and every 6 months thereafter, respectively. The volumes of the nodules were compared before MWA and at each follow-up point after MWA. The volume reduction rate (VRR) of nodules was also calculated.

Results

The mean volume of the nodules was 134.3 ± 129.8 mm³ initially (the range was 7.4–423.8 mm³), which decreased significantly to 2.3 ± 10.5 mm³ (the range was 0–48.1 mm³) of the ablation area (P = 0.000) at the follow-up point of 36 months with a mean VRR as 98.78 ± 5.61% (the range was 74.28–100%). During the follow-up period (the range was 36–48 months), 20 of the 21 nodules were completely absorbed and no recurrent nodule was found.

Conclusions

After a long-term follow-up of 3 years, the low power MWA showed a good safety and efficacy for the treatment of PTMC. In addition to surgery and active surveillance, MWA might be another alternative for patients with PTMC.

Brito JP, Morris JC, Montori VM (2013) Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 347:f4706 https://doi.org/10.1136/bmj.f4706 CrossRefPubMed

Cheng Z et al (2017) US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter. Study Sci Rep 7:9554. https://doi.org/10.1038/s41598-017-09930-7 PubMed

Feng B, Liang P, Cheng Z, Yu X, Yu J, Han Z, Liu F (2012) Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol 166:1031–1037. https://doi.org/10.1530/EJE-11-0966 CrossRefPubMed

Gambelunghe G et al (2013) Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from a three-year pilot study. Surg Innov 20:345–350. https://doi.org/10.1177/1553350612459276 CrossRefPubMed

Gharib H et al (2016) American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules—2016 update. Endocr Pract 22:622–639. https://doi.org/10.4158/EP161208.GL CrossRefPubMed

Griffin A, Brito JP, Bahl M, Hoang JK (2017) Applying criteria of active surveillance to low-risk papillary thyroid cancer over a decade: how many surgeries and complications can. Be avoided? Thyroid 27:518–523. https://doi.org/10.1089/thy.2016.0568 CrossRefPubMed

Haser GC et al. (2016) Active surveillance for papillary thyroid microcarcinoma: new challenges and opportunities for the health care system. Endocr Pract 22:602–611 https://doi.org/10.4158/ep151065.ra CrossRefPubMedPubMedCentral

Haugen BR et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated Thyroid Cancer. Thyroid 26:1–133. https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentral

Ito Y, Oda H, Miyauchi A (2016) Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [review]. Endocr J 63:323–328. https://doi.org/10.1507/endocrj.EJ15-0637 CrossRefPubMed

Ito Y, Miyauchi A, Oda H (2017) Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials. Eur J Surg Oncolo J Eur Soc Surg Oncol Br Assoc Surg Oncol. https://doi.org/10.1016/j.ejso.2017.03.004

Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, Lee D (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250. https://doi.org/10.1007/s00330-008-0880-6 CrossRefPubMed

Jiao D et al (2010) Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol 136:1507–1516. https://doi.org/10.1007/s00432-010-0808-9 CrossRefPubMed

Kim J-h et al (2016) Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperth 33:212–219. https://doi.org/10.1080/02656736.2016.1230893 CrossRef

Korkusuz H, Happel C, Koch DA, Gruenwald F (2016a) Combination of ultrasound-guided percutaneous microwave ablation and radioiodine therapy in benign thyroid disease: a 3-month follow-up. Study Rofo 188:60–68. https://doi.org/10.1055/s-0041-106538 PubMed

Korkusuz Y et al (2016b) Microwave ablation of symptomatic benign thyroid nodules: energy requirement per ml volume reduction. Rofo 188:1054–1060. https://doi.org/10.1055/s-0042-115416 CrossRefPubMed

Korkusuz Y et al (2016c) Cooled microwave ablation of thyroid nodules: Initial experience. Eur J Radiol 85:2127–2132. https://doi.org/10.1016/j.ejrad.2016.09.019 CrossRefPubMed

Li X, Fan WJ, Zhang L, Zhang XP, Jiang H, Zhang JL, Zhang H (2013) CT-guided percutaneous microwave ablation of liver metastases from nasopharyngeal carcinoma. J Vasc Interv Radiol JVIR 24:680–684. https://doi.org/10.1016/j.jvir.2013.02.005 CrossRefPubMed

Li M, Yu X, Liang P, Dong B, Liu F (2015) Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperth 31:579–587. https://doi.org/10.3109/02656736.2015.1014869 CrossRef

Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH (2013) Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 23:1044–1049. https://doi.org/10.1007/s00330-012-2671-3 CrossRefPubMed

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317:1338–1348. https://doi.org/10.1001/jama.2017.2719 CrossRefPubMed

Liu W et al (2017a) Risk factors of central lymph node metastasis of papillary thyroid carcinoma: a single-center retrospective analysis of 3273 cases. Medicine 96:e8365. https://doi.org/10.1097/md.0000000000008365 CrossRefPubMedPubMedCentral

Liu YJ, Qian LX, Liu D, Zhao JF (2017b) Ultrasound-guided microwave ablation in the treatment of benign thyroid nodules in 435 patients. Exp Biol Med (Maywood) 242:1515–1523. https://doi.org/10.1177/1535370217727477 CrossRef

Papini E et al (2013) Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab 98:E92-97. https://doi.org/10.1210/jc.2012-2991 CrossRef

Papini E et al (2014) Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab 99:3653–3659. https://doi.org/10.1210/jc.2014-1826 CrossRefPubMed

Qu P, Yu X, Liang P, Cheng Z, Han Z, Liu F, Yu J (2013) Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Ultrasound Med Biol 39:1571–1579. https://doi.org/10.1016/j.ultrasmedbio.2013.03.030 CrossRef

Shaha AR, Tuttle RM (2017) Risk of disease progression during active surveillance of papillary thyroid cancer. Surgery. https://doi.org/10.1016/j.surg.2017.08.020 PubMed

Shin JE, Baek JH, Lee JH (2013) Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol 25:14–19. https://doi.org/10.1097/CCO.0b013e32835a583d CrossRefPubMed

Tuttle RM et al (2017) Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg 143:1015–1020. https://doi.org/10.1001/jamaoto.2017.1442 CrossRefPubMed

Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM (2010) Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 20:1253–1261. https://doi.org/10.1089/thy.2010.0189 CrossRefPubMed

Wang B et al. (2017) Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation. Int J Hyperth. https://doi.org/10.1080/02656736.2016.1274058

Wu W, Gong X, Zhou Q, Chen X, Chen X, Shi B (2017) US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules. Endocr J 64:1079–1085. https://doi.org/10.1507/endocrj.EJ17-0152 CrossRefPubMed

Yu J et al (2014) US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology 270:880–887. https://doi.org/10.1148/radiol.13130275 CrossRefPubMed

Yue W, Wang S, Wang B, Xu Q, Yu S, Yonglin Z, Wang X (2013) Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol 82:e11–e16. https://doi.org/10.1016/j.ejrad.2012.07.020 CrossRef

Yue W, Wang S, Yu S, Wang B (2014) Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperth 30:150–157. https://doi.org/10.3109/02656736.2014.885590 CrossRef

Yue W, Chen L, Wang S, Yu S (2015) Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: a prospective study. Int J Hyperth 31:403–408. https://doi.org/10.3109/02656736.2015.1014433 CrossRef

Zhang M, Luo Y, Zhang Y, Tang J (2016) Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma. A prospective study. Thyroid 26:1581–1587. https://doi.org/10.1089/thy.2015.0471 CrossRefPubMed

Titel: Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study
verfasst von: Dengke Teng
Guoqing Sui
Caimei Liu
Yu Wang
Yongxu Xia
Hui Wang
Publikationsdatum: 09.02.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-018-2607-7

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Clinical characteristics and outcomes of cancer patients requiring intensive care unit admission: a prospective study

Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis

Ballroom dancing as physical activity for patients with cancer: a systematic review and report of a pilot project

Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients

Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis

Commentary on: Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie